NewsMore in News→
WHO Condemns US-Funded Newborn Hepatitis B Vaccine Trial as Unethical
Key Takeaways
- The $1.6M CDC-funded trial would study 14,500 infants, withholding the birth dose from half in a country where 1 in 5 carry hepatitis B
- Over 115 countries include the hepatitis B birth dose in their immunization schedules; the vaccine has been used for 30+ years
- Guinea-Bissau suspended the trial pending review; Africa CDC is sending an evaluation team
DE
DT Editorial Team··2 min read·via arstechnica.com